Cardiac arrest survival rates have improved with modern resuscitation techniques, but many survivors experience impairments associated with hypoxic-ischemic brain injury (HIBI). Currently, little is understood about chronic changes in striatal dopamine (DA) systems after HIBI. Given the common empiric clinical use of DA enhancing agents in neurorehabilitation, investigation evaluating dopaminergic alterations after cardiac arrest (CA) is necessary to optimize rehabilitation approaches. We hypothesized that striatal DA neurotransmission would be altered chronically after ventricular fibrillation cardiac arrest (VF-CA). Fast-scan cyclic voltammetry was used with median forebrain bundle (MFB) maximal electrical stimulations (60Hz, 10s) in rats to characterize presynaptic components of DA neurotransmission in the dorsal striatum (D-Str) and nucleus accumbens 14 days after a 5-min VF-CA when compared to Sham or Na€ ıve. VF-CA increased D-Str-evoked overflow [DA], total [DA] released, and initial DA release rate versus controls, despite also increasing maximal velocity of DA reuptake (V max ). Methylphenidate (10 mg/kg), a DA transporter inhibitor, was administered to VF-CA and Shams after establishing a baseline, pre-drug 60 Hz, 5 s stimulation response. 
The annual incidence of cardiac arrest (CA) due to nontraumatic cardiac causes is 111 per 100 000, culminating iñ 360 000 cases/year in the United States (Mozaffarian et al. 2015) . Survival rates for CA in North Americans are estimated at 8.4% (Nielsen et al. 2013; Guyette et al. 2015) , and rates improve to 39% when the initial rhythm is ventricular fibrillation (Mozaffarian et al. 2015) . While survival has improved with modern resuscitation and targeted temperature management (Guyette et al. 2015) , CA survivors may exhibit multiple motor and cognitive impairments due to the neurological sequelae resulting from the associated hypoxic-ischemic brain injury (HIBI) (Andersson et al. 2015; Tiainen et al. 2015) .
The thalamus, cerebellum, hippocampus, cortical interneurons and striatum are most affected by CA (Bj€ orklund et al. 2014; Brisson et al. 2014) . Also, striatal medium spiny neurons (MSNs) are particularly vulnerable to ischemia (Galvin and Oorschot 2003; Wu et al. 2006) and are among the earliest to exhibit irreversible ischemic damage (Pulsinelli et al. 1982) . One explanation for MSN ischemic vulnerability is glutamate toxicity exacerbated by dopamine (DA) modulation, which is a mechanism for topographical cell loss in Huntington's disease (HD) (Stack et al. 2007; Rebec 2013; Lewerenz and Maher 2015) . This hypothesis is compelling given the dense dopaminergic innervation of the striatum and studies demonstrating acute uncontrolled DA release even after mild hypoxic-ischemic insult (Broderick and Gibson 1989; Huang et al. 1994) , which are much greater than ischemia-induced increases of other neurotransmitters (Katayama et al. 1991; Kondoh et al. 1994) . In particular, MSNs with type 2 dopamine receptors (D2R), which are implicated in dystonia, chorea, and cognitive disorders (Charvin et al. 2005; van Oostrom et al. 2005; Dale et al. 2012; Groman and Jentsch 2012; Karimi and Perlmutter 2015) are particularly metabolically vulnerable to dysfunction/damage associated with Huntington's Disease (Reiner et al. 1988; Deng et al. 2004) , findings which are similar to what occurs with transient global ischemia (Meade et al. 2000) .
Most studies evaluating striatal injury have focused on global ischemia models at acute time points. However, little is known about chronic DA system changes. As dopaminergic system alterations underlie motor symptoms in Parkinson's disease (PD) and HD (Bird 1980) , DA neurotransmission changes after CA may provide insight into CAassociated motor abnormalities like post-hypoxic myoclonus that result in functional impairment and disability (Frucht and Fahn 2000; Budhram et al. 2014) . Also, disinhibited DA release and striatal imbalance in other elements of DA transmission, may lead to hypoarousal cognitive disorders that impair function after HIBI associated with CA (Cronberg et al. 2009; Andersson et al. 2015; Tiainen et al. 2015) .
Clinically, individuals surviving CA have many of the same cognitive behavioral features as those with significant traumatic brain injury (TBI) (Sawyer et al. 2017 ) and many impairments associated with TBI relate to striatal dopamine system dysfunction that occurs without overwhelming evidence of direct striatal damage in both clinical populations (Wagner et al. 2014 ) and experimental studies (Yan et al. 2007; Wagner et al. 2009b) . The primary DA neurotransmission derangements documented with the controlled cortical impact model of experimental TBI suggest a state of functional hypodopaminergia (Bales et al. 2009 ). However, one may hypothesize that selective vulnerability of MSNs after surviving CA may lead to dysregulated DA transmission or possibly a functional hyperdopaminergia. From a clinical perspective, and the fact that current neurorehabilitation treatment approaches are empiric and often derived from current practice with other brain injury types like TBI, it is important to understand if/how striatal DA neurotransmission after ventricular fibrillation CA (VF-CA) compares to previously published derangements in experimental TBI models. The hypodopaminergic state observed chronically after TBI, supports the common use of dopaminergic stimulants in this population (Wagner et al. 2005 (Wagner et al. , 2009a ; yet, our review of the clinical literature (Chatelle et al. 2014; Sawyer et al. 2017) , along with our own clinical experience (Pinto et al. 2017) , suggests that DA stimulants worsen cognitive and motor symptoms associated with HIBI, and alternative neuropharmacology is needed and can improve functional recovery.
We used in vivo fast scan cyclic voltammetry (FSCV), similar to our previous experimental TBI studies, to monitor electrically stimulated DA neurotransmission in a rat model of 5-min VF-CA survival. We assessed DA neurotransmission in a consistently survivable VF-CA preparation to characterize DA neurotransmission dysfunction at an insult duration that does not cause frank striatal damage in order to begin to characterize CNS sequelae associated with VF-CA survival. As ischemia produces degeneration of MSNs like HD, we hypothesized VF-CA may cause HD-like disinhibition of striatal DA release from the substantia nigra pars compacta (SNpc) (Celada et al. 1999; Lee et al. 2004) . We also conducted western blots to assess striatal DA pathway receptor and enzymatic protein changes associated with VF-CA. Given the common use of DA agonists like methylphenidate to address cognitive dysfunction and arousal after TBI (Neurobehavioral Guidelines Working Group et al. 2006; Bales et al. 2009 ), we also evaluated the effects of a pharmacological challenge to methylphenidate (MPH) on DA neurotransmission in this model.
Methods
This study was approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. Twenty-six adult male Sprague-Dawley rats (350-400 g; Harlan, IN, USA) successfully survived surgical procedures, and striatal voltammetric signals were obtained using the FSCV protocol outlined below (n = 9 VF-CA; n = 9 Sham, n = 8 Na€ ıve). Rats were arbitrarily selected as a na€ ıve control or to undergo the VF-CA model or Sham procedures prior to initiating the FSCV protocol. Researchers conducting the FSCV protocol were blinded to rat group assignment. Rats were placed in standard housing in pairs prior to surgical procedures, and then housed alone after recovery from survival surgery procedures. Standard housing included unrestricted access to food and water as well as a 12 h dark/light cycle.
Ventricular fibrillation cardiac arrest (VF-CA) model
The protocol has been described in detail previously (Janata et al. 2013 (Janata et al. , 2014 . In brief, adult male Sprague-Dawley rats (350-400 g; Envigo, Frederick, MD, USA) were housed for at least 3 days before the experiment under 12-h light/dark cycle with unrestricted access to food and water. On the day of the experiment, rats were anesthetized with isoflurane 4% in inspiration fraction of oxygen (FiO 2 ) 1.0 for 4 min, intubated with a 14 gauge intravenous catheter (Becton Dickinson, Sandy, UT, USA) and mechanically ventilated (Harvard Rodent Ventilator 683; Harvard Apparatus, South Natick, MA, USA; tidal volume 6 mL/kg, initial respiratory rate 40/min, positive endexpiratory pressure 5 cm H 2 O, FiO 2 0.5), while maintaining normothermia with an overhead lamp and a heating pad. Anesthesia was maintained with isoflurane 2%. Left femoral artery and vein were cannulated with polyethylene (PE) tubing (PE60 and PE90, respectively, Masterflex, Barnant, IL, USA) for blood pressure monitoring and drug administration, respectively, via surgical cutdowns. Baseline arterial blood gas (ABG) was obtained to assess acid-base balance and hematologic parameters with glucose and lactate.
In rats assigned to the VF-CA group, a 5 French bipolar pacing catheter (Edwards LifeSciences, Irvine, CA, USA; catalogue # D97130F5; Figure S1a ) was advanced to the right ventricle via the jugular vein. After completion of instrumentation, isoflurane was decreased to 1% for 9 min, and FiO 2 was decreased to 0.25. After 9 min of isoflurane washout, isoflurane was discontinued for 1 min to decrease potential protective effects of volatile anesthetics on brain and mirror clinical scenario. Rats were then disconnected from the ventilator and VF-CA was induced by a 12 V/50 Hz alternating current (2-3 mA for 120 s) applied to the endocardium of the right ventricle via the pacing catheter. Application of electrical current to the endocardium resulted in an instant cessation of blood flow ( Figure S1b , top left panel). The current was sustained for 2 min to prevent spontaneous defibrillation. This catheter was then removed during ongoing VF-CA. After 5 min VF-CA, epinephrine 50 lg/kg and bicarbonate 1 mmol/kg were given intravenously at the start of cardiopulmonary resuscitation (CPR) ( Figure S1b , top center panel). Additional epinephrine 25 lg/kg was given 60 s after the start of CPR. Resuscitation was performed with mechanical ventilation (FiO 2 1.0, identical respiratory parameters as above) and manual chest compressions (300/min) until return of spontaneous circulation (ROSC). If ROSC was not achieved within 2 min of CPR, rats were defibrillated (Zoll 3M, Chelmsford, MA, USA; 10J biphasic shock between sternal and esophageal electrode positioned behind the heart); defibrillation attempts were repeated if needed every 30 s during ongoing CPR ( Figure S1b , top right panel and bottom panel; Figure S1c ). Sham rats received all surgical procedures except those directly associated with VF-CA and resuscitation under isoflurane anesthesia (1% with FiO 2 identical to the corresponding stage of the VF-CA protocol).
Post-resuscitation care
Arterial blood gases were obtained at 5 min (post-ROSC), 30 min (prior to weaning from the ventilator) and 60 min (after weaning from the ventilator) resuscitation time. Rats were weaned from the ventilator at 30 min after ROSC, allowed to breathe spontaneously via endotracheal tube with supplemental oxygen delivered via nosecone mask at 2L/min. By using a midline laparotomy incision, a Mini-mitter probe (Mini-Mitter Co., Sunriver, OR, USA) was introduced into the peritoneal cavity to allow post-operative temperature control, and continuous monitoring of vital functions. After decannulation, rats were extubated 60 min after ROSC. Rats were then placed in cages, kept normothermic using overhead heating lamp and/or fan for 18 h, and provided with supplemental oxygen (2L/min for 18 h) and unlimited access to food and water. The Mini-mitter probe was removed 24 h later under brief isoflurane anesthesia via a nose-cone mask. Rats were then moved to the housing facility with 12 h dark/light cycle, and unlimited access to standard chow and water. Rats were housed individually with standard environmental enrichment. Neurologic function was assessed daily for the first 3 days, using an Overall Performance Category (OPC) score (1 = normal -ambulating, eating, drinking; 2 = mild disability -as OPC 1 but with abnormal sensory or motor function; 3 = moderate disability -responds to pain, no ambulation, no righting, no eating or drinking, conscious; 4 = severe disabilityno ambulation, no righting, no eating or drinking, comatose; 5 = death) (Carrillo et al. 1998 ) and a modified Neurologic Deficit Score (NDS; 0-10% = normal, 100% = maximum deficit) (Neumar et al. 1995; Janata et al. 2013) .
Fast-scan cyclic voltammetry
Rats that were Na€ ıve or underwent Sham/VF-CA procedures 2 weeks prior were prepared for voltammetric studies for the evaluation of regional alterations of DA neurotransmission as described previously (Harun et al. 2015a-c) . In brief, rats were anesthetized with urethane (1.3 g/kg), mounted onto a stereotaxic apparatus, and maintained at 37°C with a homoeothermic blanket (Harvard Apparatus, Holliston, MA, USA). Midline incisions were made and soft tissues reflected to expose the skull to drill burr holes for the placement of carbon fiber microelectrodes. Carbon fiber microelectrodes were fabricated as described previously (Harun et al. 2015a,b) . Immediately prior to use, electrodes were electrically pretreated with a 70 Hz biphasic cyclic waveform (0V?2V? 0V) to enhance sensitivity for DA. Two recording microelectrodes were simultaneously inserted using flatskull coordinates (in mm) into the dorsal striatum [anterioposterior (AP) +1.7, mediolateral (ML): 1.4, and dorsoventral (DV): À3.4] and into the nucleus accumbens core (AP: 1.0, ML: 2.1, and DV: À6.6) (Paxinos and Watson 2007) . A reference electrode was placed in proximal soft tissue to create a salt bridge. A bipolar stimulating electrode (MS301-1; Plastics One, Roanoke, VA, USA) was inserted into the median forebrain bundle (AP: À4.0, ML: 1.6, DV: À6.6).
Biphasic 60 Hz, 5 s (280 lA amplitude and 2 ms pulse width) stimulations of the median forebrain bundle were used to evoke DA overflow. DA responses were electrochemically detected by the carbon fiber microelectrodes to which a triphasic cyclic voltage waveform (0V?1V?0.5V?0V) was applied at a rate of 400 V/s every 100 ms, using TarHeel CV software (ESA, Chelmsford, MA, USA). The stimulating electrode was advanced 200 lm every 5 min until a DA signal was detected and then lowered 100 lm every 10 min until a peak signal amplitude was obtained in both electrodes. Experimental DA responses were then obtained using alternating 60 and 40 Hz stimulations for 5 or 10 s according to the schematic depicted in Fig. 1 . For data analysis purposes, we applied 5 and 10 s recordings at 60 Hz stimulation prior to any drug injection. We then applied 60 Hz, 5 s stimulations at 10 and 35 min after MPH administration as well as 40 Hz 5 s stimulations at 25 and 50 min after MPH administration.
After obtaining baseline stimulations, 10 mg/kg MPH or 1 mL/kg phosphate buffered saline was administered intraperitoneally. 10 min later rats underwent two rounds of alternating 60 Hz, 5 s and 40 Hz, 5 s stimulations followed by 15 and 10 min rest periods, respectively.
Following electrode explantation, electrodes were calibrated with seven standard DA concentrations in artificial cerebrospinal fluid (pH = 7.2) composed of (in mM): 1.2 CaCl 2 , 2.0 Na 2 HPO 4 , 1.0 MgCl 2 , 2.7 KCl, 145 NaCl (Harun et al. 2015) . The DA concentration versus current calibration plot was fit using a quadratic regression, which was then used to convert experimental DA responses from measured currents to DA concentrations.
Interpretation of DA responses
DA response shape analysis DA response shapes were assessed by evaluating peak DA concentrations associated with experimental DA response amplitudes, or evoked overflow (EO) [DA] . Moreover, we found the effects of MPH were more pronounced during the initial portion of stimulated DA responses, when competitive DA transporter (DAT) inhibitors are predicted to exert their greatest effects on DA response shapes. As such, we evaluated the response amplitude 1 s into the stimulation (EO 1s ) of pre/post-MPH administration responses.
Quantitative model of dopamine dynamics
As validated and used in previous studies, we implemented the quantitative neurobiological (QN) framework to model kinetic parameters onto DA responses to 60 Hz, 10 and 5 s stimulations obtained from VF-CA, Sham, and Na€ ıve rats (Harun et al. 2015a-c) . Instead of characterizing DA release and reuptake using a classic Michaelis-Menten model (Wightman and Zimmerman 1990) , we used the dynamic QN framework, which does not presume constant DA release rate or a constant reuptake efficiency and affinity for DA on the part of DAT. The equations and terms that the QN model utilizes to describe the release and reuptake components of stimulated DA responses are reproduced in Table 1 . Briefly, DA release rate during stimulation (DAR stim ) is described by eqn 1 as an exponential decay function with a time constant of ΔDARs and a steady-state release rate (DAR ss ) . Post-stimulation DA release rate (DAR post ) is described in eqn 2 as release rate that decreases biphasically after stimulation ends, with a rapid exponential and prolonged linear decay components. Lastly, reuptake kinetics was modeled similar to the M-M model, except K m was defined as a dynamic term that increases during stimulation according to the logistic function in eqn 3 to model a decreasing reuptake efficiency caused by the stimulation itself. To model experimental data systematically, we set the initial K m (K mi ) to a value between 0.1 and 0.4 lM and estimated the time constant for the rapid component for post-stimulation DA release (s R ) to s R % 0.6 s for 5 s stimulations and s R % 1.2 s for 10 s stimulations similar to our previous report (Harun et al., 2015b) . The simulations provided estimates of DA release and reuptake rates over the time course of stimulated DA responses. In particular, we examined four parameters that were derived from these simulations to characterize the effects of VF-CA on stimulated DA neurotransmission-K mi , V max , initial DA release rate (DAR i ), and V max . K mi describes the M-M constant that estimates the efficiency of DAT molecules at physiological conditions, and V max is an estimate of maximal reuptake rate that depends upon local DAT density and efficiency. As DA release is a dynamic process during stimulation, we provided estimates of DAR i and total estimated DA released during stimulation by integrating DA release rate equations over the stimulation duration.
Western blotting
Striata from both hemispheres were collected at 2 weeks after VF-CA (N = 9) or Sham (N = 9), frozen on dry ice, and stored at À80°C. Tissue was sonicated in lysis buffer and prepared for western blotting as previously published (Posimo et al., 2015) . Denatured proteins were separated with standard electrophoresis and transferred to nitrocellulose membranes. Membranes were exposed overnight to primary antibodies (see Table 2 ) after 1 hlong exposure to 50% Odyssey Block (LI-COR, Lincoln, NE, USA) in Tris-buffered saline (TBS). On the following day, unbound primary antibodies were rinsed off with three exchanges of TBS with tween, and the blots were exposed to infrared fluorescent secondary antibodies (Jackson Immuno-Research, West Grove, PA, USA) for 1 h. Unbound secondary antibodies were then rinsed off in three exchanges of TBS-tween, and labeling was visualized on an Odyssey Imager (LI-COR). Fluorescent intensities were quantified, using ImageStudio Lite software (LI-COR) and expressed as a function of the loading control proteins, beta-actin or glyceraldehyde-3-Phosphate dehydrogenase (GAPDH).
Statistical analysis
As this was an exploratory characterization of DA transmission kinetics and protein expression, sample sizes were based on estimated numbers needed to generate 6-7 rats for the VF-CA group and 4-5 rats for the Sham and na€ ıve groups. This sample size is consistent with previously published voltammetry studies using the controlled cortical impact injury model to assess injury differences in DA neurotransmission (Wagner et al. 2005 (Wagner et al. , 2009a . All voltammetric DA response metrics were analyzed, using SPSS 24.0 (SPSS Inc., Chicago, IL, USA). Mean AE SEM (standard error of the mean) or AE/À SD (standard deviation) are reported. Group differences in DA neurotransmission kinetic parameters for 60 Hz 10 s stimulations were assessed via analysis of variance (ANOVA) with Tukey's adjustment for post hoc pairwise comparisons. Time-dependent changes were evaluated with the repeated measures analysis of variance. Two-factor repeated measures analysis of variance (RMANOVA) was used to determine treatment differences over time after MPH administration among VF-CA and Sham groups, with least square mean comparisons made to characterize group differences at individual time points. The p-values ≤ 0.05 were deemed statistically significant. For remaining data, a two-tailed unpaired Student's t-test was employed to determine significant differences between means for VF-CA versus Sham at alpha = 0.05 (Graphpad Prism 6.0, La Jolla, CA, USA).
Results

VF-CA insult and neurological impairment
Rats resuscitated from VF-CA exhibited significant hemodynamic impairment with initial hypertensive bout at resuscitation time (RT)5, followed by a blood pressure nadir at RT10 and gradual recovery and stabilization. Mean arterial pressure remained higher than Shams at the delayed 
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post-resuscitation phase (Fig. 2a) . Heart rate in the postresuscitative phase was initially lower than in Shams, with no differences between groups in later time points (Fig. 2b) . Biochemically, VF-CA resulted in significant derangements that were gradually normalized during post-resuscitative phase. However, lactate, hematocrit, and glucose remained significantly higher in VF-CA versus Shams at RT60. In contrast, paO 2 was lower after VF-CA (Table 3) . Neurologic impairment was present in both groups, with worse NDS on days 1 through 3 in VF-CA versus Sham. NDS decreased over time in both groups and was in mild (< 10%) at RT72 (Fig. 2c) . OPC was normal in all rats at RT72 with no differences between groups (data not shown).
Regional voltammetric responses and evoked overflow in striatum Electrically stimulated DA responses reflect a balance of DA release and reuptake dynamics. Figure 3 (a) and (b) depicts the average stimulated DA responses in the nucleus accumbens (NAc) and dorsal striatum (D-Str) to a maximal 60 Hz, 10 s stimulation. EO DA was higher in VF-CA rats compared to Sham in the NAc (Fig. 3c) ; in D-Str, EO DA was higher in VF-CA rats compared to both Sham and Na€ ıve rats (Fig. 3d) , with EO [DA] levels > 200% higher than either Sham or Na€ ıve.
Ventricular fibrillation cardiac arrest induces changes in regional striatal DA kinetics In order to estimate the relative contributions of DA release and reuptake from experimental DA responses, FSCV data was modeled, using the QN framework as described previously (Harun et al. 2015a,b (Fig. 4a) .
In contrast, in the D-Str, VF-CA rats exhibited significantly higher total evoked [DA] release compared to both Na€ ıve and Sham groups (Fig. 4b) . Similarly, no differences in initial DA release rate were noted in the NAc between groups (Fig. 4c) , but VF-CA caused a significant increase in the initial DA release rate in the D-Str compared to both Sham and Na€ ıve rats (Fig. 4d) . In the setting of increased D-Str DA release, QN simulations of V max in D-Str showed increased V max among VF-CA rats compared to both Sham and Na€ ıve rats. No differences in V max were noted in the NAc (Fig. 4e and f) .
Differential effects of methylphenidate DA neurotransmission after ventricular fibrillation cardiac arrest An examination of DA response amplitudes and data modeling parameters demonstrated VF-CA caused marked changes in regional stimulated DA release and reuptake kinetics. These changes in baseline DA neurotransmission characteristics may translate to altered pharmacodynamic responses to dopaminergic agents as we have demonstrated previously in our rodent TBI model (Wagner et al. 2009b) . Thus, we examined responses to a pharmacological challenge to MPH (10 mg/kg) in the Sham and VF-CA groups. Figure 5 (a) and (b) shows that in both regions, there were significant differences, or trends toward significant differences, between groups for maximum EO [DA] after MPH treatment. Figure 5 (c) and (d) shows patterns of initial EO 1s , where baseline EO 1s is nearly identical for VF-CA versus Sham rats, yet EO 1s is significantly higher for VF-CA rats after MPH treatment in both regions. This MPH-induced augmentation in EO 1s was significantly more pronounced in the D-Str for VF-CA rats versus Sham (p = 0.003) and also tended to be more pronounced in the NAc for VF-CA versus Sham (p = 0.08). The QN model was also used to simulate changes in DA neurotransmission kinetics with MPH treatment. Figure  6 (a-d) shows that while the total DA released and initial DA release rate were higher in D-Str for VF-CA rats compared to Shams, MPH treatment largely did not affect these parameters. In contrast, Fig. 6 (e-h) show that MPH had a significant impact on DA reuptake parameters. In the NAc, MPH significantly increased K m i in Shams at both 25 and 50 min time points post-MPH, as is expected for a competitive DAT inhibitor. However, K mi was only significantly increased from baseline at 25 min post-MPH in the VF-CA group. MPH increased K mi for both VF-CA and Shams in DStr, but paired t-tests show that the effect was only significant in VF-CA rats at one or the other time point after MPH injection.
Many dopaminergic agents can alter plasmalemmal DAT expression to regulate V max in a dose and time-dependent manner (Furman et al. 2009; Harun et al. 2015b) , including competitive DAT inhibitors like cocaine and methylphenidate (Krause et al. 2000; Daws et al. 2002; Little et al. 2002) . In this study, MPH had no significant effect on V max in the NAc. In the D-Str, baseline V max for VF-CA was 180 AE 8% compared to Sham in D-Str. Importantly, MPH significantly reduced V max in D-Str for VF-CA rats, but had no effect on Shams.
VFB induces increased striatal dopamine transporter protein expression Striatal tissue lysates were examined by western blot (Fig. 7) . There was no significant change in the dopaminergic phenotypic marker tyrosine hydroxylase (TH), either at the total protein level or with serine 40 phosphorylation levels. However, DAT levels were significantly upregulated (178 AE 22%) in the VF-CA group versus Shams. The vesicular monoamine transporter vesicular monoamine transporter was not similarly affected. Furthermore, there were no changes in two striatal MSN markers, namely, the DA receptor D2 and the enzyme glutamic acid decarboxylase 65/67.
Discussion
Cardiac arrest causes global cerebral ischemia, which can ultimately lead to HIBI among survivors. Although numerous studies in pre-clinical models focus on acute pathophysiology, fewer evaluate subacute and chronic effects including DA neurotransmission. As dopaminergic systems are involved in many cognitive, behavioral, and motor functions, and contribute significantly to impairments associated with other forms of acquired brain injury, neurodegenerative disease, and neuropsychiatric disorders, we investigated electrically stimulated DA neurotransmission in the 5-min VF-CA model. Evaluating DA neurotransmission in this mild (5 min) VF-CA preparation is relevant to individuals with (survivable) VF-CA, in that our findings could ultimately be important to the victims of CA with the greatest potential for benefit from rehabilitation if treatments were specifically tailored to HIBI secondary to CA rather than simply extrapolated from TBI and other clinical populations. We demonstrated that unlike the hypodopaminergic state observed in TBI models (Wagner et al. 2005 (Wagner et al. , 2009b , and clinical TBI (Donnemiller et al. 2000; Whyte et al. 2004; Kim et al. 2012; Wagner et al. 2014) , VF-CA induced increased electrically evoked striatal DA overflow 2-weeks after insult. Our kinetic analyses suggest these increases in evoked DA overflow after VF-CA are due to enhanced DA release, despite increases in V max .
Increased V max noted in kinetic analysis was corroborated, in part, by significantly increased striatal DAT expression. An 180 AE 8% increase in V max in the D-Str for VF-CA rats versus Sham with 60 Hz 5 s stimulation is similar to the 178 AE 22% increase in striatal DAT expression for VF-CA versus Sham noted on western blot. Proportional reductions in V max and DAT expression have been noted in our experimental TBI model (Wagner et al. 2005) . This work supports other clinical evidence demonstrating DAT expression changes as one compensatory mechanism by which striatal DA neurotransmission is modulated in an effort to maintain homeostasis after CNS insult (Donnemiller et al. 2000; Wagner et al. 2014) .
HD is a functionally hyperdopaminergic disease in its early stages (Deng et al. 2004; Calabresi et al. 2014) , and the clinical symptoms associated with this condition can be worsened with DA agonists (Waugh et al. 2008) . Methylphenidate is a commonly used DAT inhibitor in the clinical care of individuals with TBI (Neurobehavioral Guidelines Working Group et al. 2006; Bales et al. 2009 ), and our previous animal work (Wagner et al. 2009b) shows a single dose can effectively increase evoked DA responses in the controlled cortical impact injury model of TBI. Given the drug's clinical relevance, and the premise that VF-CA patients may not respond to DA agonists in the same manner as TBI patients (Sawyer et al. 2017), we chose MPH as a clinically relevant, and effective, agent to assess DA neurotransmission response with pharmacological manipulation. Specifically, we found that there were larger changes in DA in the D-Str for the VF-CA group compared to Shams, findings which may have implications for VF-CA-associated behavioral sequelae.
Consistent with the increased V max for VF-CA rats, we found VF-CA rats were more sensitive to the competitive DAT inhibitor, MPH, as demonstrated by greater MPHinduced increases in EO 1s ( Fig. 5c and d) . In our simulations, we constrained K mi to 0.1-0.4 lM to systematically evaluate differences in DA release and V max across groups, but limits the ability to evaluate group differences in K m i that relate to possible functional changes in DAT. Moreover K m i has subtle effects on overall DA response shape characteristics, that contribute to variability in estimating K mi values. Nevertheless, as expected for a competitive DAT blocker, MPH increased K mi for both the Sham and VF-CA groups, indicating MPH decreased the apparent affinity of DA for DAT. We found MPH reduced V max in the VF-CA group but not Shams (Fig. 6g and h ). These changes in V max may be related to previously reported effects of DAT inhibitors on altering the surface expression of DAT available for DA reuptake (Daws et al. 2002; Little et al. 2002; Volz et al. 2008) . Reasons for this group-based difference are unclear, but it may be related to high baseline V max in the VF-CA group and lower V max compared to Shams.
Increased DA release with VF-CA may result from greater DA synthesis or stronger coupling of release to stimulation. To investigate the possibility of altered DA neosynthesis in the VF-CA model, we examined the phosphorylation status of tyrosine hydroxylase (TH), the rate-limiting step of DA synthesis, on its Serine 40 (Ser40) residue. TH phosphorylation at Ser40 reduces the K m for the cofactor tetrahydrobiopterin and raises the Ki for DA, which facilitates TH activity by relieving it of its catecholamine end-product inhibition (Tekin et al. 2014) . A previous study demonstrated reduced pSer40 TH (pTH) in an experimental TBI model with concomitantly reduced TH activity (Shin and Dixon 2011) . pTH expression tended to be lower in VF-CA rats, indicating decreased enzymatic activity and associated DA synthesis might be a compensatory mechanism to reduce the hyperdopaminergic state observed 2-weeks after VF-CA. Future work should investigate whether longer hypoxicischemic insult durations might further reduce pTH.
Striatal DA release by dopaminergic projections from SNpc is regulated in part by GABAergic feedback from MSNs (Grace and Bunney 1985; Celada et al. 1999; Lee et al. 2004) . Hence, MSN dysfunction may have led to increased stimulated DA release among VF-CA rats. SNpc modulation is complex as it receives direct and indirect GABAergic feedback from MSNs (Grace and Bunney 1984; Celada et al. 1999) . Striatal MSNs may be vulnerable to HIBI insults due to the metabolic demands of their hyperpolarized baseline membrane potentials (Calabresi et al. 2000) . Given the known vulnerability within D2-expressing indirect pathway MSNs in HD models (Reiner et al. 1988; Richfield et al. 1995; Menalled et al. 2000) and the decreased striatal D2R levels in other animal models of HIBI (Benfenati et al. 1989; Chang et al. 1993; Davis et al. 2002) , we predicted D2R expression would be affected by our 5-min VF-CA model. However, we did not observe changes in D2R expression. The lack of reduced D2R receptors expression may be due to the brief duration of VF-CA, supporting the view there was no overt cell death and consistent with previous work showing no overt striatal cell death even after a 6-min VF-CA (Janata et al. 2013) . However, D2R expression can occur on presynaptic DA terminals and post-synaptic MSNs, confounding our ability to identify specific reductions in post-synaptic D2R gene expression using western blot.
Initially, we hypothesized MSN dysfunction after HIBI may alter DA release, presumably by altering globus pallidus (GP)-mediated GABAergic feedback to the SNpc (Celada et al. 1999; Lee et al. 2004) . The evolution of hyperdopaminergia after mild VF-CA, despite no change in glutamic acid decarboxylase 65/67 levels evaluated on western blot, suggests MSN dysfunction, instead of cell death, may disrupt subcortical DA circuitry enough to facilitate enhanced striatal-evoked overflow, particularly in the D-Str. Future work may examine whether/how restoring GP GABAergic tone after CA, using selective GABA receptor subunit agents like zolpidem, may normalize complex GP-thalamo-cortical circuitry and evoked striatal DA outflow (Daniele et al. 2016) , as well as determine if/ how this agent affects motor (Daniele et al. 2016) and cognitive (Chatelle et al. 2014; Giacino et al. 2014) function among CA survivors. Historically, MSNs were considered similar in anatomic structure and physiological function (Gertler et al. 2008) . However, recent studies suggest increased excitability and less dendritic arborization for D2R expressing MSNs (Gertler et al. 2008; Gittis and Kreitzer 2012) which may impact their relative vulnerability to ischemic insult. Also, cortical glutamatergic projections to D1 MSNs are distinct from cortical projections to D2 MSNs (Lei et al. 2004) , which may differentially influence excitotoxicity, susceptibility to ischemic damage. While not addressed here, future work may focus on selective vulnerability of MSNs to damage or dysfunction from VF-CA and associated relationships with striatal DA neurotransmission.
Notably, we demonstrated more pronounced changes in DA kinetics 2-weeks after VF-CA in D-Str, which is selectively vulnerable in PD (Kish et al. 1988; Fearnley and Lees 1991; Blair 2010; Guatteo et al. 2017) . Similarly, our recent work suggests that the D-Str is more vulnerable to experimental TBI, with more profound DA release and reuptake impairments noted compared to NAc (Harun et al., 2015c) . Thus, there may be shared pathomechanisms of DAergic dysfunction between PD, brain injury, and VF-CA. For instance, regional vulnerability may be related to greater DAT density in D-Str compared to the NAc (Ciliax et al. 1995; Blair 2010) , which can sequester toxic DA-derived species into neurons especially under conditions of increased DA turnover or oxidative stress like ischemia (Heikkila and Cohen 1973; Chan 2001) . Moreover, dopaminergic projections to D-Str maybe more vulnerable after ischemia because they are more energetically demanding, owing to greater terminal arborization compared to NAc-projecting dopaminergic neurons (Matsuda et al. 2009; Pissadaki and Bolam 2013) . The D-Str and NAc receive DAergic innervation from distinct midbrain nuclei-the SNc and ventral tegmental area (VTA), respectively, which differ in neuronal projection density, morphology, neurochemistry, and intrinsic firing properties that may contribute to their differential vulnerability in disease contexts (Mosharov et al. 2009; Chuhma et al. 2017; Guatteo et al. 2017) . Future work should focus on examining VF-CA mediated damage versus dysfunction to these nuclei to address primary midbrain damage versus circuit feedback disruption as contributing to the striatal hyperdopaminergia observed with this study.
The nature and duration of our VF-CA model may have limited the changes observed with D2R expression and presumed cell survival. Rats subjected to VF-CA showed a recovery pattern consistent with our prior reports from similar insults (Janata et al. 2013 (Janata et al. , 2014 . The mortality rate associated with our VF-CA model was just 11%, compared to the reported 61% mortality rate for out of hospital VF-CA (Mozaffarian et al. 2015) , signifying a more severe HIBI clinically may be accompanied by more striatal neurotransmission deficits. Studies suggest that inflammation can have significant impact on multiple parameters associated with striatal DA neurotransmission (including release and reuptake) (Felger and Miller 2012; Felger et al. 2015; Felger and Treadway 2017) as well as DA relevant behaviors like anhedonia and anxiety (Felger and Miller 2012; Miller et al. 2013; Felger and Treadway 2017) . Our previous work with the VF-CA model shows persistent striatal Iba staining (Janata et al. 2013) , indicative of microglial activation in the dorsal striatum, despite little to no Fluorajade C staining at 2 weeks after a 6 min VF-CA. Additional work from our group suggests robust increases in tumor necrosis factor-alpha in the striatum after 6 min VF-CA (Janata et al. 2013 (Janata et al. , 2014 . Taken together with the data presented in this report, one hypothesis for dysfunctional striatal DA neurotransmission, despite minimal changes in most striatal protein expression profiles (except DAT) with mild VF-CA, may be ongoing neuroinflammation. Interestingly, some work using the middle cerebral artery occlusion model of ischemia shows that activated microglia express both Iba and D2 receptors (Huck et al. 2015) in ischemic brain, suggesting that striatal neuroinflammation may contribute to striatal D2 receptor expression associated with HIBI sustained after VF-CA.
The changes in DA neurotransmission observed also indicate the possibility of associated behavioral deficits. However, the VF-CA model is too new and uncharacterized in terms of behavioral sequelae to readily know what tasks are sensitive to and reflective of striatal dysfunction associated with VF-CA. Thus, this area of research is a valuable avenue to pursue as a future direction across a range of insult durations and severities of striatal damage/ dysfunction. Among others, post-hypoxic myoclonus (Truong et al. 1994) , as well as measures of anhedonia (Papp et al. 1991) and anxiety (Pellow et al. 1985; Walf and Frye 2007) may be DA relevant behaviors to characterize in the VF-CA model. Importantly, many individuals surviving CA are addicted to opiates and have an asphyxial CA. Given that for a similar insult duration, asphyxial CA produces more brain injury than VF-CA (Tsai et al. 2012; Varvarousis et al. 2015) , and also baseline differences in striatal DA function with chronic opiate use (Miller et al. 2005; Steidl et al. 2011; Lobo et al. 2013) , future studies assessing CA associated striatal DA neurotransmission derangements should reflect differences in insult type and baseline differences in striatal function present in specific clinical populations surviving CA.
Our data demonstrate a relatively brief, survivable VF-CA confers an early chronic phase (2-weeks post-arrest) functional hyperdopaminergic state, a finding not previously reported in any model of CA or cerebral ischemia. Moreover, this hyperdopaminergic state is exacerbated by MPH administration relative to Sham. These findings suggest caution in prescribing DA agonists in the rehabilitation of HIBI, where hyperdopaminergia and associated cognitive, behavioral, and motor symptoms may be further exacerbated with agents like MPH. More research may assess the time-course of hyperdopaminergia after experimental HIBI and treatments for achieving DA homeostasis after insult.
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